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Alain Guilloux
1 With  memories  of  the  2003  SARS  outbreak  still  fresh,  this  study  focuses  on  the
governance system that made it possible to control the epidemic in a record time. As
Fidler finished his manuscript in August 2003, barely two months after World Health
Organisation (WHO) lifted its global alert. SARS may return, the author warns, but he
hopes that his book will be helpful regardless. 
2 Undeniably, the fight against SARS was a success. Less than four months after WHO
issued its first global alert, control was in sight as transmission had been interrupted
everywhere. Fidler’s narrative takes us through the sequence of events that caused an
unknown disease to spread globally from a single floor of the Metropole Hotel in Hong
Kong.  The  alert  immediately  launched  by  the  WHO,  the  travel  advisories  and
containment measures put in place, the scientific race to identify the causative agent
and the global efforts to roll back SARS are now history.
3 The author’s main argument is that this success highlights a change of paradigm. We
have moved, he writes, from a Westphalian to a post-Westphalian health governance
system. The former was minimally intrusive. In the wake of early nineteenth century
cholera  epidemics,  major  powers  were  primarily  anxious  to  minimise  disorderly
quarantine measures,  which  disrupted  trade.  At  the  first  international  health
conference convened in 1851, the points of agreement were limited to the notification
and  control  of  three  diseases :  cholera,  yellow  fever  and  plague.  These  so-called
“Asiatic”  diseases  were  brought  to  Europe  from Asia  by  way of  maritime trade.  In
contrast, malaria was never included in the agenda of nineteenth century international
health conferences. The reason is that malaria was endemic in parts of Europe, and that
any regulation affecting the sovereignty of a European state was at the time out of the
question. 
4 Today’s efforts to contain these and other infectious diseases face similar obstacles.
Governments sign up to international health treaties, but routinely flout them. How
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global,  or  post-Westphalian,  is  the  governance  system  that  addresses  cross-border
public health issues ? What has changed, according to Fidler, is that information flows
freely across borders and governments no longer have the exclusive right to report
outbreaks, as Non Governmental Organisations (NGOs) are also empowered to do so. 
5 However,  in  the  case  of  SARS,  the  recently  established  global  alert  and  response
network of the WHO was far from seamless, instant or ubiquitous. True, collaborative
efforts proceeded well and fast, after the alarm bell rang. But before that, SARS most
likely roamed around Southern China for several months. We may never know for sure
what happened exactly, as sensitive information does not freely flow out of, or within,
China.  In  addition,  both  local  and  foreign  NGOs  face  restrictions,  as  the  Chinese
government  views  them  with  suspicion.  China  initially  failed  to  acknowledge  the
problem,  until  a  retired  Army  doctor  pushed  the  government  to  face  up  to  its
responsibilities.
6 Fidler’s chapter on China misses the complexities of the Hong Kong and Taiwan issues.
Here is a major power that deeply antagonised the public opinion of its prized Hong
Kong  SAR  and  struggled  hard  to  keep  all  Taiwanese  health  officials  out  of  the
containment loop. Including these perspectives would obviously have weakened the
author’s  point  on  the  irrelevance  of  borders,  be  they  internal,  to  global  health
governance. 
7 Equally arguable is the author’s view that an “unchained” WHO suddenly found itself in
a position to dictate terms to governments, be they the most powerful. His claim that
the US, though not enthusiastic, could not resist WHO’s zeal, is not credible. That the
US administration would have felt shy of flexing its muscles here, had it disagreed with
WHO’s approach, is a perplexing claim. As the Bush administration was preparing to
invade Iraq, the US was presumably keen to avoid getting embroiled in yet another
controversy. But it remains to be seen whether WHO will have a free hand in dealing
with future outbreaks. 
8 Fidler insists that the control of SARS was a global good. Nobody would dispute that.
Obviously, everyone felt threatened by a disease that struck all, rich and poor, North
and South, East and West in a record time. But what exactly constitutes a global public
good for health ? According to the author, it is one that benefits more than one region
or  continent.  Surprisingly,  Fidler  nevertheless  mentions  that,  although  it  affects
hundreds of millions of people in Africa and Asia and kills over one million each year,
malaria fails to qualify as a global disease as cross-border transmission is low1.  This
leaves us wondering whether a disaster has to threaten rich people seriously, if it wants
to be recognised as global. Should a narrow view of what constitutes a global good for
health prevail, the new governance paradigm would be bad news for millions of people
affected by malaria, sleeping sickness, leishmaniasis and other neglected diseases in
low-income countries.
9 Beyond SARS, this book raises important questions. How best should the world prepare
to respond to the deadly outbreaks WHO warns us will inevitably happen ? One need
not  necessarily  share  Professor  Fidler’s  optimism  or  his  enthusiasm  for  a  post-
Westphalian Utopia. But his book is enjoyable, well-written and thought-provoking.
David P. Fidler, SARS, Governance and the Globalization of Disease
China Perspectives, 63 | january - february 2006
2
NOTES
1. Richard D. Smith & al. (eds.), Global public goods for health : Health economic and public
health perspectives, Oxford, Oxford University Press, 2003.
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